200 related articles for article (PubMed ID: 17668415)
21. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Bandiera E; Rossi E; Donzelli C; Pasinetti B; Pecorelli S; Santin AD
Am J Obstet Gynecol; 2007 Mar; 196(3):245.e1-11. PubMed ID: 17346539
[TBL] [Abstract][Full Text] [Related]
22. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
[TBL] [Abstract][Full Text] [Related]
23. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R
Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882
[TBL] [Abstract][Full Text] [Related]
24. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
[TBL] [Abstract][Full Text] [Related]
25. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
Kim SW; Kim JW; Kim YT; Kim JH; Kim S; Yoon BS; Nam EJ; Kim HY
Genes Chromosomes Cancer; 2007 Jan; 46(1):1-9. PubMed ID: 17044060
[TBL] [Abstract][Full Text] [Related]
26. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
[TBL] [Abstract][Full Text] [Related]
27. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
28. New applications and developments in the use of multiplex ligation-dependent probe amplification.
Kozlowski P; Jasinska AJ; Kwiatkowski DJ
Electrophoresis; 2008 Dec; 29(23):4627-36. PubMed ID: 19053154
[TBL] [Abstract][Full Text] [Related]
29. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Crum CP; Drapkin R; Miron A; Ince TA; Muto M; Kindelberger DW; Lee Y
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):3-9. PubMed ID: 17218844
[TBL] [Abstract][Full Text] [Related]
30. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
Tapper J; Bützow R; Wahlström T; Seppälä M; Knuutila S
Br J Cancer; 1997; 75(12):1782-7. PubMed ID: 9192982
[TBL] [Abstract][Full Text] [Related]
31. Precursors to pelvic serous carcinoma and their clinical implications.
Folkins AK; Jarboe EA; Roh MH; Crum CP
Gynecol Oncol; 2009 Jun; 113(3):391-6. PubMed ID: 19237187
[TBL] [Abstract][Full Text] [Related]
32. Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles.
May T; Shoni M; Crum CP; Xian W; Vathipadiekal V; Birrer M; Rosen B; Tone A; Murphy KJ
Gynecol Oncol; 2013 Mar; 128(3):488-92. PubMed ID: 23253401
[TBL] [Abstract][Full Text] [Related]
33. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
[TBL] [Abstract][Full Text] [Related]
35. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
Körner M; Burckhardt E; Mazzucchelli L
J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
[TBL] [Abstract][Full Text] [Related]
36. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast.
Marchiò C; Iravani M; Natrajan R; Lambros MB; Savage K; Tamber N; Fenwick K; Mackay A; Senetta R; Di Palma S; Schmitt FC; Bussolati G; Ellis LO; Ashworth A; Sapino A; Reis-Filho JS
J Pathol; 2008 Aug; 215(4):398-410. PubMed ID: 18484683
[TBL] [Abstract][Full Text] [Related]
37. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.
Piek JM; Kenemans P; Verheijen RH
Am J Obstet Gynecol; 2004 Sep; 191(3):718-32. PubMed ID: 15467531
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
40. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
